2-(m-Tolyl)thiazole

Catalog No.: 
ACTABF216
CAS No.: 
42156-13-8
Molecular Formula: 
C10H9NS
Molecular Weight: 
175.26
2-(m-Tolyl)thiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$86.00InquiryInquiry
1g95%$264.00InquiryInquiry
5g95%$1294.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(m-Tolyl)thiazole
IUPAC Name2-(m-tolyl)thiazole
Molecular FormulaC10H9NS
Molecular Weight175.26
SMILESCC1=CC(C2=NC=CS2)=CC=C1
InChI KeyZYAYLXRHPOSSRA-UHFFFAOYSA-N
Synonym2-o-tolylthiazole;2-(3-Tolyl)thiazole;Thiazole, 2-(3-methylphenyl)-;2-(3-Methylphenyl)thiazole
CAS No.42156-13-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTABF216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBSHU170 route compound structure diagram
    ACBSHU1703034-53-5In Stock
  2. Plus
  3. ACEUNQ805 route compound structure diagram
    ACEUNQ80517933-03-8In Stock
  4. Then
  5. ACTABF216 route product structure diagram
    ACTABF21642156-13-8
Inquiry

2. ACTABF216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUNQ805 route compound structure diagram
    ACEUNQ80517933-03-8In Stock
  2. Plus
  3. ACBIYF954 route compound structure diagram
    ACBIYF9543034-54-6In Stock
  4. Then
  5. ACTABF216 route product structure diagram
    ACTABF21642156-13-8
Inquiry

3. ACTABF216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMOEW520 route compound structure diagram
    ACMOEW5202362-63-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTABF216 route product structure diagram
    ACTABF21642156-13-8
Inquiry

Comments (0)